| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/18/2003 | WO2003061570A3 Engineered binding proteins |
| 09/18/2003 | WO2003060068A3 Oxa1p enhanced protein secretion |
| 09/18/2003 | WO2003059252A3 Use of a novel cell surface protease from group b streptococcus |
| 09/18/2003 | WO2003057130A3 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 09/18/2003 | WO2003050247A3 Antisense modulation of mhc class ii transactivator expression |
| 09/18/2003 | WO2003046135A3 Osteopontin-related compositions and methods |
| 09/18/2003 | WO2003039595A3 Mucosal adjuvants comprising an oligonucleotide and a cationic lipid |
| 09/18/2003 | WO2003038082A3 Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants |
| 09/18/2003 | WO2003035861A3 Thrombin-cleavable chimeric proteins |
| 09/18/2003 | WO2003033692A3 Use of the adenoviral e2 late promoter |
| 09/18/2003 | WO2003026584A3 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 09/18/2003 | WO2003025191A3 Pseudotyped retroviral vector system |
| 09/18/2003 | WO2003020974A3 Methods for detecting dna originating from different individuals in one sample |
| 09/18/2003 | WO2003014347A3 Plant seed specific promoters |
| 09/18/2003 | WO2003012139A3 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene |
| 09/18/2003 | WO2003012113A3 Inducible expression systems employing ppar transcriptional activators |
| 09/18/2003 | WO2003008599A3 System for producing clonal or complex populations of recombinant adenoviruses, and the application of the same |
| 09/18/2003 | WO2003008441A3 Moringa seed proteins |
| 09/18/2003 | WO2003006644A3 Lipase/acyltransferase |
| 09/18/2003 | WO2003004675A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 09/18/2003 | WO2003004671A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 09/18/2003 | WO2003004521A3 Nucleotide sequence and method for increasing the resistance to disease in plants |
| 09/18/2003 | WO2002103022A3 Transgenic cells expressing clucosyltransferases which glucosylate parabenzoic acid |
| 09/18/2003 | WO2002103015A3 Abca10 transporter |
| 09/18/2003 | WO2002102411A3 Method for treating psoriasis by using an il-17d antagonist |
| 09/18/2003 | WO2002097125A3 Tools for the diagnosis, molecular definition and development of treatment of chronic inflammatory joint diseases |
| 09/18/2003 | WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |
| 09/18/2003 | WO2002095070A3 Polynucleotide sequencing method |
| 09/18/2003 | WO2002094868A3 Staphylococcus aureus proteins and nucleic acids |
| 09/18/2003 | WO2002090372B1 Products containing charged biomaterials and method for the preparation thereof |
| 09/18/2003 | WO2002083184A3 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| 09/18/2003 | WO2002080982A3 Nucleic acid mucosal immunization |
| 09/18/2003 | WO2002077267A3 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 09/18/2003 | WO2002077174A3 Human cytokine receptor |
| 09/18/2003 | WO2002072790A3 Tsg101-gag interaction and use thereof |
| 09/18/2003 | WO2002072027A3 Oncolytic rna replicons |
| 09/18/2003 | WO2002066646A3 Neurotransmission-associated proteins |
| 09/18/2003 | WO2002064793A3 G protein-coupled receptor-like proteins and nucleics acids encoding same |
| 09/18/2003 | WO2002064628A3 Isolated human transporter proteins nucleic acids and use thereof |
| 09/18/2003 | WO2002060914A3 Identification of small rnas and orfs form e. coli as mediators of cell and intercell regulation |
| 09/18/2003 | WO2002059308A3 Method of diagnosing and treating cartilage disorders |
| 09/18/2003 | WO2002057458A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/18/2003 | WO2002050287A3 Multifunctional protease inhibitors and their use in treatment of disease |
| 09/18/2003 | WO2002042459A3 Position dependent recognition of gnn nucleotide triplets by zinc fingers |
| 09/18/2003 | WO2002040641A3 Binary bac vector and uses thereof |
| 09/18/2003 | WO2002036810A3 Antisense modulation of talin expression |
| 09/18/2003 | WO2002036625A9 Prokineticin polypeptides, related compositions and methods |
| 09/18/2003 | WO2002029056A3 Mini-dystrophin nucleic acid and peptide sequences |
| 09/18/2003 | WO2002014503A3 Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies |
| 09/18/2003 | WO2002006536A3 Methods and compositions for perioperative genomic profiling |
| 09/18/2003 | WO2002000687A9 Antimicrobial peptides and methods of use thereof |
| 09/18/2003 | US20030177547 Imprinting in plants to control gene expression |
| 09/18/2003 | US20030177546 Genetic engineered plant; uniform particles |
| 09/18/2003 | US20030177545 Inbred corn line G0302 |
| 09/18/2003 | US20030177542 Inbred corn line G2202 |
| 09/18/2003 | US20030177541 Produced by crossing the inbred corn plant 5750 with itself or with another corn plant, such as another inbred |
| 09/18/2003 | US20030177539 Genetic engineering; fungi tolerance; chemical resistance |
| 09/18/2003 | US20030177537 Transgenic plant; genetic engineering |
| 09/18/2003 | US20030177536 Transgenic plant; genetic engineering |
| 09/18/2003 | US20030177535 Genes for altering mitochondrial function and for hybrid seed production |
| 09/18/2003 | US20030177534 Genetic engineered polypeptide; biosynthesis of cationic starch |
| 09/18/2003 | US20030177533 Variants of ADP-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters |
| 09/18/2003 | US20030177532 Manipulation of starch granule size and number |
| 09/18/2003 | US20030177531 Regulating metabolism by modifying the level of trehalose-6-phosphate by inhibiting endogenous trehalase levels |
| 09/18/2003 | US20030177530 From cereals; transgenic plant; heat resistance; genetic engineering |
| 09/18/2003 | US20030177529 Transforming plant cell with expression vector |
| 09/18/2003 | US20030177528 Genes encoding novel proteins with pesticidal activity against Coleopterans |
| 09/18/2003 | US20030177527 Nucleotide sequences coding signal transduction components in durable and broad-range resistance strategies based on plant defence |
| 09/18/2003 | US20030177526 Receptors for hypersensitive response elicitors and uses thereof |
| 09/18/2003 | US20030177525 Determination nematode resistance; soybean seeds |
| 09/18/2003 | US20030177524 To uridine-5-monophosphate; nucleic acid coding decarboxylase |
| 09/18/2003 | US20030177522 Genetic engineering; hybrids; transformated plants, seeds |
| 09/18/2003 | US20030177521 Plastid transformation of solanaceous plants |
| 09/18/2003 | US20030177520 Transgenic plant; genetic engineering |
| 09/18/2003 | US20030177519 Promoters and utilization thereof |
| 09/18/2003 | US20030177518 Plant gene |
| 09/18/2003 | US20030177517 Transformed plant cell |
| 09/18/2003 | US20030177515 Rodent embryo stem cell; genetic engineering; lacking gene expression for erythropoietin |
| 09/18/2003 | US20030177513 Insertion genome; activation; generating embryo |
| 09/18/2003 | US20030177511 Antitumor, anticancer agents |
| 09/18/2003 | US20030177510 Testing drug, therapy for Alzheimer's disease using transgenic animal |
| 09/18/2003 | US20030177507 Transgenic animal model; determination variations in plaque deposits |
| 09/18/2003 | US20030176688 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
| 09/18/2003 | US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease |
| 09/18/2003 | US20030176680 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF) |
| 09/18/2003 | US20030176679 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 09/18/2003 | US20030176678 Viricides, antitumor agents, antiproliferative agents, anticancer agents; genetic engineered Dna |
| 09/18/2003 | US20030176675 TyrA genes and uses thereof |
| 09/18/2003 | US20030176673 Fermentation of fusion protein; genetic engineering |
| 09/18/2003 | US20030176671 Controlling cell differentiation, cell proliferation; transgenic plant, animal |
| 09/18/2003 | US20030176667 Transfroming growth factor; drug design |
| 09/18/2003 | US20030176666 Hypothalamus-specific polypeptides |
| 09/18/2003 | US20030176661 Novel antibody with specificity for colon cancer |
| 09/18/2003 | US20030176657 Binding to antibodies; wound healing agent; cell proliferation stimulant |
| 09/18/2003 | US20030176653 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 09/18/2003 | US20030176652 Human and mouse beta-defensins, antimicrobial peptides |
| 09/18/2003 | US20030176651 Multiprotein-complex comprising a nmda receptor and uses thereof |
| 09/18/2003 | US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 09/18/2003 | US20030176648 Ion channel |
| 09/18/2003 | US20030176647 Antibodies to OCIF-binding molecules |